Mhaidat et al. found that docetaxel induces apoptosis in TRAIL-resistant melanoma cells through caspase-2 activation, which leads to mitochondrial changes and the subsequent activation of caspase-9 and caspase-3, alongside PARP degradation. The gene discussed is CASP2; the disease is melanoma.